John Hsuan

Overview

John Hsuan is a Taiwanese entrepreneur and investor with a focus on healthcare, biotechnology, and medical sectors. He is the founder of Meridigen Biotech Co., a stem-cell drug company, and the chairman of Hukui Biotechnology Corporation, which provides turnkey services to global medical device customers. Hsuan has also served as the honorary vice chairman of United Microelectronics Corp (UMC), a leading semiconductor company in Taiwan. His investments span various sectors, including medical electronics, digital health, and telemedicine. Hsuan's investment strategy emphasizes early-stage funding, particularly in Series A and Series B rounds, targeting companies in Taiwan and China. His portfolio includes companies involved in medical devices, biotechnology, and healthcare services. He has been instrumental in facilitating collaborations between Taiwanese firms and mainland China, aiming to expand the reach of Taiwan's biotech industry. With over 40 years of experience in Taiwan's semiconductor industry, Hsuan has co-founded numerous companies, many of which have been successfully listed on major exchanges or over-the-counter markets. His extensive network and expertise have enabled him to identify and support promising ventures in the healthcare and biotechnology sectors, contributing to the growth and innovation of these industries in the region.

Investment Focus

• Innovative healthcare solutions
• Scalable business models
• Experienced management teams
• Strong market potential in Taiwan and China
• Alignment with Hsuan's strategic vision

Portfolio Companies